Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.9 GBX | +1.83% | +1.09% | +53.59% |
05-01 | Poolbeg Pharma Secures Full Patent in US for Immunomodulator II | MT |
05-01 | Poolbeg Pharma celebrates full patent approval for Immunomodulator II | AN |
End-of-day quotes
Sector Bio Therapeutic Drugs
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
88.14M | - | - | - | - | - | |
124B | ||||||
112B | ||||||
22.94B | - | |||||
22.22B | - | |||||
17.02B | - |
- Stock Market
- Equities
- POLB Stock
- Charts Poolbeg Pharma PLC
- Sector Chart